NOTE – this seminar will be held in Swedish. What we eat affects our health and how we perform. This is a well-established fact, but further knowledge about the relationship between nutrition and human health isn’t as widespread. With GoCo Arenas second digital seminar on Nutrition, Health and Performance, we invite you to learn more.
Researchers identify a new biomarker for the childhood cancer neuroblastoma
NEW STUDY. In collaboration with researchers in the Netherlands and Belgium, researchers at the University of Gothenburg have now shown that overexpression of the gene for ALKAL2 activates a chain of other cancer-driving genes and how this leads to neuroblastoma. The results indicate that increased gene dosage of ALKAL2 may become a new biomarker and open up the potential for treatment with ALK inhibitors for certain forms of childhood cancer.…
Researchers can begin applying to use SCAPIS data from March 17
RESEARCH. The launch of unique SCAPIS is approaching. SCAPIS is a bank of data, blood samples and bioimages from 30,000 participants that will be openly available for researchers throughout the country and eventually the world. “Our vision is to find the individuals at risk of cardiovascular disease and chronic obstructive pulmonary disease so that they can receive treatment earlier,” says Göran Bergström, director of SCAPIS, professor at the University of…
The research day 2021 will be moved to the autumn of 2021
Due to the latest developments regarding covid-19 and the introduction of the new pandemic law, the Research Day planned to be held on February 4th 2021 unfortunately needs to be postponed. Healthcare is currently in a strained situation and many employees have to prioritize covid care. With a maximum limit of 8 participants, it will also be practically impossible to complete the day as planned. The day is instead planned…
New studies support blood test for early detection of Alzheimer’s disease
NEW STUDIES. In three recent publications in Molecular Psychiatry, Brain and JAMA Neurology researchers from the University of Gothenburg provide convincing evidence that an in-house developed blood test for Alzheimer’s disease can detect the disease early and track its course, which has major implications for a potential use in clinical practice and treatment trials. “This is an extremely dynamic research field right now, thanks to the technological development and seminal scientific progress in the past…